5:06
Gender-attributable differences in outcome of ankylosing spondylitis
Oxford Academic (Oxford University Press)
2:59
Top Tips on Getting Published in Rheumatology (Journal)
2:25
EULAR 2016 Rheumatology Case of the Conference explained
4:37
Relapse and treatment outcomes in biopsy-proven giant cell arteritis
4:17
The effect of allopurinol on all-cause mortality in adults with incident gout.
5:00
The ‘Don’t Retard’ project for people with juvenile idiopathic arthritis
3:36
Twenty-two points to consider for clinical trials in systemic sclerosis
5:05
The impact of primary Sjögren’s syndrome on female sexual function
5:36
Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary SS?
3:31
Rheumatology: EULAR 2014 'Cases of the Day'
12:11
Rheumatology: Risk of infections associated with rheumatoid arthritis
8:40
The Impact of Biologic Therapy on Rheumatoid Arthritis
5:33
Analysis of extended follow-up data from the interferon α kinoid phase I/II study
5:18
The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis
6:07
Management of Sjögren's syndrome with Dr Elizabeth Price
5:57
BSR and BHPR Guideline for the prescription and monitoring of non-biologic DMARDs
The BSR Guideline for the Management of Gout with Dr Ed Roddy
5:50
Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
7:05
Risk Factors of Serious Infections in Patients with Rheumatoid Arthritis
3:42
BSR and BHPR guideline for the treatment of axial spondyloarthritis with biologics
7:16
Marwan Bukhari, Incoming Editor-in-Chief, speaks with Jaap van Laar | Oxford Academic
6:02
Dr Marwan Bukhari talks to Professor Dennis McGonagle | Rheumatology
4:28
Dr Marwan Bukhari talks to Professor Ernest Choy on JAK inhibitors | Rheumatology
2:54
Dr Marwan Bukhari on how to write an abstract
5:30
Dr Marwan Bukhari on peer review
1:33
Richard Watts on Rheumatology Advances in Practice
Dr Marwan Bukhari talks to Dr Edward Vital on his Michael Mason prize-winning presentation
4:13
Dr Roy Fleischmann: ‘Long-term safety of sarilumab in rheumatoid arthritis'
14:38
Retrospectively reviewing polymyositis diagnoses in a large single-centre cohort
